MEI Pharma Inc (MEIP)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current MEIP market cap is 19.86M. The company's latest EPS is USD -4.7784 and P/E is -0.62.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.89M | 1.46M | 65.3M | 0 | 0 |
| Operating Income | -16.39M | -11.08M | 55.28M | -11.93M | -9.83M |
| Net Income | -15.44M | -10.03M | 56.37M | -11.06M | -9.13M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.92M | 28.91M | 25.54M | 40.7M | 48.82M |
| Operating Income | -46.25M | -24.54M | -69.69M | -75.48M | -36.76M |
| Net Income | -16.82M | -46.02M | -50.58M | -54.45M | -31.84M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 134.19M | 120.81M | 101.25M | 78.54M | 71.26M |
| Total Liabilities | 99.83M | 96.19M | 19.89M | 19.05M | 20.23M |
| Total Equity | 34.35M | 24.62M | 81.36M | 59.49M | 51.03M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 82.66M | 209.73M | 174.1M | 177.84M | 120.81M |
| Total Liabilities | 34.73M | 131.51M | 132.74M | 125.43M | 96.19M |
| Total Equity | 47.93M | 78.22M | 41.36M | 52.41M | 24.62M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -41.18M | -52.48M | -18.49M | -29.55M | -32.47M |
| Investing | 34.29M | 53.69M | 4.96M | 29.47M | 29.6M |
| Financing | -40k | -40k | N/A | -11.66M | -11.66M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -29.42M | 34.26M | -31.96M | -48.75M | -52.48M |
| Investing | 24.32M | -106.29M | 24.71M | 6.89M | 53.69M |
| Financing | 1.39M | 74.78M | 3.47M | 49.05M | -40k |
| Market Cap | 19.86M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 0.41 |
| Price to Cash Ratio | 1.17 |
| Price to Book Ratio | 0.81 |
| Dividend Yield | - |
| Shares Outstanding | 6.66M |
| Average Volume (1 week) | 28.1k |
| Average Volume (1 Month) | 15.98k |
| 52 Week Change | -61.60% |
| 52 Week High | 7.8734 |
| 52 Week Low | 2.7293 |
| Spread (Intraday) | 0.16 (5.28%) |
| Company Name | MEI Pharma Inc |
| Address |
1209 orange st wilmington, delaware 19801 |
| Website | https://www.meipharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
